Suzuken Co., Ltd. Hits Day Low of JPY 4,906 Amid Price Pressure

Suzuken Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable decline today, with the stock dropping by 5.1% as of May 14, 2026. The stock reached an intraday low of JPY 4,906.00, reflecting ongoing challenges in its market performance. Over the past week, Suzuken has seen a decrease of 8.06%, and its monthly performance has been even more pronounced, with a drop of 15.9%. Year-to-date, the stock is down 18.14%, significantly underperforming the Japan Nikkei 225, which has gained 24.46% during the same period. Despite a three-year performance increase of 27.22%, the company has struggled to maintain momentum, with a one-year return of -1.24%. Financial metrics indicate a low debt level and sufficient cash reserves, yet the company has faced challenges in net sales growth, which has averaged only 2.77% annually over the last five years. With a return on equity of 9.20% and a price-to-book ratio of 0.97, Suzuken's valuation remains attractive, although it trades at a premium compared to its peers.